What is ArteraAI?
ArteraAI is a leading precision medicine company that develops AI tests to personalize cancer therapy. Their AI test provides individualized results, enabling personalized treatment decision-making between clinicians and patients.
Features of ArteraAI
- Multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests
- The first and only AI test to be recommended in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer for predictive and prognostic performance
- Predicts therapy benefit and determines prognosis for patients with localized prostate cancer
- Analyzes digital pathology images and ingests clinical data
- Does not consume tissue and provides results within 2-3 days after receipt of the patient's specimen
How to Use ArteraAI
- Order the ArteraAI Prostate Test for your patient
- Start your order and share the information with your doctor today
- Be your own advocate and share this information with your doctor today
Benefits of ArteraAI
- Empowers clinicians with predictive and prognostic data
- Supports shared decision-making for clinicians and patients
- Provides individualized results that better inform physicians in the treatment decision-making process
- Allows for a more personalized approach to cancer therapy
- Does not consume tissue and provides results within 2-3 days after receipt of the patient's specimen
Frequently Asked Questions
- What is ArteraAI? ArteraAI is a leading precision medicine company that develops AI tests to personalize cancer therapy.
- What is the ArteraAI Prostate Test? The ArteraAI Prostate Test is a multimodal artificial intelligence (MMAI) based predictive and prognostic cancer test that predicts therapy benefit and determines prognosis for patients with localized prostate cancer.
- How does the ArteraAI Prostate Test work? The test analyzes digital pathology images and ingests clinical data to provide individualized results that better inform physicians in the treatment decision-making process.
- What are the benefits of the ArteraAI Prostate Test? The test empowers clinicians with predictive and prognostic data, supports shared decision-making for clinicians and patients, and allows for a more personalized approach to cancer therapy.
Helpful Tips
- ArteraAI is a leading precision medicine company that develops AI tests to personalize cancer therapy.
- The ArteraAI Prostate Test is a multimodal artificial intelligence (MMAI) based predictive and prognostic cancer test that predicts therapy benefit and determines prognosis for patients with localized prostate cancer.
- The test does not consume tissue and provides results within 2-3 days after receipt of the patient's specimen.
Price
- The price of the ArteraAI Prostate Test is not specified on the website. Please contact ArteraAI for more information.